Actinic Keratosis: Why We Treat It and How

Part of: Skin cancer & dermatologic surgery

Actinic keratosis treatment choices: freezing, field creams, light treatment, and biopsy warning signs.

Skin cancer · 2 min read · September 10, 2026

Written and medically reviewed by Dr. Yousef Abo Zarad · German board-certified dermatologist · Last reviewed: September 2026

The short answer

Actinic keratosis is a rough or scaly lesion associated with cumulative UV damage. Some lesions can progress to squamous-cell carcinoma, but it is not possible to predict reliably which will do so, so assessment and an appropriate treatment plan matter.13

Choice depends on the number, thickness and location of lesions: cryotherapy can suit individual spots, while creams or photodynamic treatment can treat a larger affected field.13

Why treat instead of watch?

  • Some actinic keratoses regress spontaneously, but this does not guarantee clearance or exclude progression in an individual lesion.23
  • A thick, bleeding, painful or rapidly enlarging lesion deserves assessment for possible biopsy rather than repeated cosmetic treatment.1
  • Surveillance matters particularly with substantial UV damage or impaired immunity.13

What are the treatment options?

  • Liquid-nitrogen cryotherapy: treats one or a few defined lesions and may cause blistering, crusting or transient pigment changes.13
  • Field therapy with 5-fluorouracil or imiquimod: evidence-supported options for areas with multiple lesions; treatment duration and schedule depend on the product and site.13
  • Tirbanibulin: a short topical course for face or scalp; availability varies by country.13
  • Photodynamic therapy (PDT): can treat a field, but the medicine, incubation period and light source vary by protocol; a universal activation time is misleading.13
  • Diclofenac and other methods: may suit selected patients, but the best choice depends on the clinical examination.13

One lesion or a whole field?

A clearly defined single lesion may be treated individually, for example with cryotherapy. If many lesions affect sun-damaged face or scalp skin, field-directed treatment addresses both visible and subclinical disease within the treated area.13

What to do during treatment

  • Redness and scaling: common during some topical regimens, particularly 5-FU; severe pain or ulceration calls for contacting the prescriber rather than automatically continuing.1
  • Steroids and moisturizers: do not add or stop products without advice; soothing care or a regimen change may be appropriate. There is no universal rule that any steroid always prevents treatment success.1
  • Sunlight: after PDT follow product-specific light-avoidance instructions and maintain daily sun protection.13
  • Pregnancy: some agents, particularly topical 5-FU, are unsuitable during pregnancy; tell the clinician before treatment.1

Follow-up after treatment

After treatment, follow-up frequency depends on lesion burden, past skin cancer, immune status and individual risk. There is no single interval for everyone, and new lesions can occur because underlying UV damage persists.13

When to see a doctor sooner

  • A lesion that grows rapidly, becomes painful, bleeds or ulcerates.1
  • A lesion that fails to improve as expected or recurs quickly after treatment.1
  • Severe intolerable treatment reactions or signs of infection.1

Medical Evidence